Filing Details

Accession Number:
0001209191-18-038886
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-06-20 21:29:07
Reporting Period:
2018-06-08
Accepted Time:
2018-06-20 21:29:07
Original Submission Date:
2018-06-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1704483 Robert Berman C/O Biohaven Pharmaceuticals, Inc.
234 Church Street
New Haven CT 06510
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2018-06-11 4,409 $35.25 316,283 No 4 S Indirect By Berman Marital Trust 2013
Common Shares Disposition 2018-06-11 55,907 $36.15 260,376 No 4 S Indirect By Berman Marital Trust 2013
Common Shares Disposition 2018-06-11 100 $36.65 260,276 No 4 S Indirect By Berman Marital Trust 2013
Common Shares Disposition 2018-06-12 10,647 $37.07 249,629 No 4 S Indirect By Berman Marital Trust 2013
Common Shares Disposition 2018-06-12 5,629 $38.00 244,000 No 4 S Indirect By Berman Marital Trust 2013
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Berman Marital Trust 2013
No 4 S Indirect By Berman Marital Trust 2013
No 4 S Indirect By Berman Marital Trust 2013
No 4 S Indirect By Berman Marital Trust 2013
No 4 S Indirect By Berman Marital Trust 2013
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.63 - $35.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.63 - $36.61, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.73 - $37.72, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.74 - $38.28, inclusive.